Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society

August 2, 2011 By Bio-Medicine.Org

PARSIPPANY, N.J., Aug. 2, 2011 /PRNewswire/ — Pacira
Pharmaceuticals, Inc.
(Nasdaq:
PCRX
), an emerging specialty pharmaceutical company, today
announced that new preclinical data evaluating the safety of
DepoFoam® with DEPC (a novel excipient) will be presented in
two podium sessions at the 38th Annual Meeting & Exposition of
the Controlled Release Society (CRS) in National Harbor, Md.
DepoFoam is Pacira’s proprietary, extended release drug delivery
technology, which is a key component of EXPAREL™ (bupivacaine
extended-release liposome injection), the company’s lead
investigational product candidate for postsurgical pain
management.

The first abstract, titled “Quantitative WholeBody
Autoradiography Following Single Subcutaneous Injection of [114C] 2erucoyl)DEPC DepoFoam Formulation in Rats,” will be presented on
Tuesday, August 2, 2011, at 4:30 p.m. EDT.  The second
abstract, titled “Safety Evaluation of a Novel Pharmaceutical
Excipient (DEPC) in EXPAREL, an Extended-Release Liposomal
Formulation of Bupivacaine,” will be presented on Tuesday, August
2, 2011, at 5 p.m. EDT. Both abstracts are being presented at a
major medical meeting for the first time.

“These new data add to the growing body of evidence supporting
the safety of DepoFoam as a proprietary, extended release drug
delivery technology,” said David Stack, president and chief
executive officer of Pacira Pharmaceuticals, Inc. “As DepoFoam is
the carrier vehicle for our lead product candidate, EXPAREL, these
presentations mark another important safety milestone for the
clinical community. We believe these data, combined with the other
positive clinical and pre-clinical data we have previously
presented, further validate the potential safety and utility of
EXPAREL in postsurgical pain management, should it be approved by
the Food and Drug Administ

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech